Bryan Lawrence

Member, Board Of Directors at Cingulate Therapeutics

Bryan Lawrence, PharmD, MBA, is an experienced leader in the pharmaceutical and healthcare consulting industries. Currently serving as a member of the Board of Directors at Cingulate Inc. since February 2024, Lawrence has held significant roles throughout his career, including Vice President of Corporate Development at AmerisourceBergen and Partner/Corporate Development Officer at Xcenda. Lawrence's background includes driving growth and strategy in various organizations, such as Applied Health Outcomes, Navigant Consulting, Johnson & Johnson, and Janssen Pharmaceutica, with a focus on managed care marketing, outcomes research, and corporate account management. Educational credentials include an MBA from The Wharton School, a Research Fellowship in Pharmacoeconomics from the University of South Carolina, and a Doctor of Pharmacy from The University of Kansas.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Cingulate Therapeutics

1 followers

Cingulate® is a biopharmaceutical company utilizing its innovative Precision Timed Release™ (PTR) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products.


Industries

Employees

11-50

Links